The LMG Life Sciences team is pleased to announce the launch of its 2023 Americas research period. As each year, we will begin a thorough survey of the life sciences legal market, seeking to recognize the top law firms and attorneys in the industry sector.

A key part of our research process is the firm submission, which will be due on May 15, 2023 (download submission form here). The submission is comprised of a practice overview and sections for matters in order to highlight legal services provided to life sciences clients. The form also includes an area to provide client referees so that we may contact them for added feedback.

Once the submission form is complete, all documents can be uploaded to our central submission portal. If you have not accessed this portal previously for LMG Life Sciences or any other Delinian research brands, you will need to create an account in order to upload.

What's new this year is we are expanding our jurisdictional coverage in the Americas to include Brazil and Mexico. If your firm is based in either country, or has an office there with a life sciences team, we are happy to receive a separate submission form covering work completed in Brazil and/or Mexico. We are accepting the same submission form linked above, we just ask that separate forms are completed for the newly added countries.

 

Please read below some useful tips and FAQs related to this year’s research:

How can I fill out the firm questionnaire and where do I submit?

The 2023 firm questionnaire template can be downloaded here. Once completed, the questionnaire can be submitted through the central submission portal.

 

Why is it important for firms to participate each year?

The least we expect from firms each year is firm questionnaire and client referees submissions. Regardless of whether your firm is currently ranked or not, it is imperative to submit these each year because everything we publish is subject to change. We believe that annual participation demonstrates that your firm’s life sciences practice is credible and active.

Furthermore, we may find information in your submission which may positively influence our decision when considering firms for the rankings, Life Sciences stars lists and awards.

 

Is there a fee to pay or cost to participate in your research?

None at all.

 

Which jurisdictions are included in the research this year?

This research launch is focused on life sciences markets in the United States, Canada, and as of this year, Brazil and Mexico. We also now cover the EMEA life sciences market, which is conducted through a separate research period beginning in the Fall. For questions about EMEA research, contact awards researcher John.Harrison@legalmediagroup.com.

 

When is the questionnaire due?

Firm questionnaires are due on May 15, 2023.

 

When do you start your interviews?

The research team will begin taking interview requests as soon as research launches on March 24, and can be scheduled for a time slot in May or June. If your firm prefers to select interviewees internally, please notify chris.adams@legalmediagroup.com before April 23, otherwise researchers may begin contacting individuals directly. Upon notification we will then coordinate through the main firm contact, instead of reaching out to your partners directly via the upcoming interview request email campaign.

Due to the volume of firms we interact with, we can allow up to 2 firm interviews maximum.

 

When and where will you publish the 2023 firm rankings and other results?

Firm rankings, attorney rankings and analysis from the 2023 research cycle will be published online in late September. The LMG Life Sciences Americas Awards results will also be announced in September.

 

Can you briefly explain the research process?

Our methodology for the firm rankings, stars lists and awards is based on a weighted system of peer, client and firm feedback, combined with an independent review of all information obtained including firm questionnaires and publicly available information. Please read more about our methodology here.